Navigation Links
24th ECNP Congress: The most promising data from research across brain disorders
Date:5/24/2011

On behalf of the European College of Neuropsychopharmacology (ECNP) we are pleased to invite you to the press conferences of the largest annual scientific meeting on neuroscience, brain disorders, and mental health in Europe, the 24th ECNP Congress in Paris.

The ECNP Congress attracts more than 7,000 psychiatrists, neurologists, psychologists and neuroscience researchers from across the world to discuss the latest advances in brain research and their implications for clinical practice, and its high-calibre programme provides a good opportunity for reporting developments of major public health importance.

The topics of the press conferences, which have been selected with an eye on their public health appeal, will feature exciting research findings as well as novel pharmacological approaches and their impact on patients quality of life.

Renowned experts from research centres in France, the United Kingdom and Germany will present the following topics:

  • The emotional brain in youth: how to diagnose and treat mood disorders in children and adolescents
    Professor David Cohen, M.D., Ph.D., France
    Sunday, 4 September 2011, from 10.00-10.45, Passy, Palais des Congrs de Paris

    Professor Cohen from the famous Piti-Salptrire hospital in Paris will briefly review the diagnostic issues and controversies surrounding bipolar disorder in youth as well as focus on the typical form of bipolar disorder in adolescents and its therapeutic approach.

  • The ECNP Networks Initiative (ENI): Innovative approaches in bipolar disorders
    Professor Guy M. Goodwin, FRCPsych, FMedSci, United Kingdom
    Sunday, 4 September 2011, from 15.00-15.45, Passy, Palais des Congrs de Paris

    Professor Goodwin will highlight a multicentre European collaboration establishing a data collection of more than 10.000 patients for conducting studies into the main psychiatric conditions, which will represent a dramatic source of new findings.

  • Size and burden of disorders of the brain in Europe - an update
    Professor Hans-Ulrich Wittchen, MD, PhD, Germany
    Monday, 5 September 2011, from 11.15-12.00, Passy, Palais des Congrs de Paris

    Professor Wittchen from the Technische Universitaet Dresden, and Vice-president of ECNP will present on behalf of the joint ECNP-EBC Task Force the latest 2011 update on prevalence, burden and cost of mental disorders in Europe. This represents an extended and updated version of our previous size and burden document (ref. European Neuropsychopharmacology 15 (2005) Special issue.)

Each press conference will be moderated by an expert of ECNP.

Please note: the press conferences will be held in English, no translation(s) will be provided.

For detailed information, please refer to the enclosed press procedures and the press registration form.

Please note: participation in the congress is free of charge for journalists but requires registration.

You can register for the 24th ECNP Congress by submitting your registration form via http://www.ecnp-congress.eu/en/press/registration.aspx

For more information on the 24th ECNP Congress, please visit the ECNP Congress website http://www.ecnp-congress.eu

For your convenience, a press kit highlighting specific aspects of the 24th ECNP Congress as well as general background information on both ECNP and the ECNP Congresses will be available at the congress site.

We hope that the 24th ECNP Congress will attract your interest and that you may join us in our efforts to enhance brain health and to promote better treatment.

We are looking forward to welcoming you to Paris.


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
431-405-5734
European College of Neuropsychopharmacology
Source:Eurekalert

Related medicine news :

1. 23rd ECNP Congress: August 28-September 1, 2010, Amsterdam, The Netherlands
2. 23rd ECNP Congress: Europes largest scientific meeting on mental health
3. Research!America urges Congress: Support medical research in 2012 budget
4. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
5. First blinded study of venous insufficiency prevalence in MS shows promising results
6. Promising therapy for relapsing multibple sclerosis
7. New strategy produces promising advance in cancer vaccines
8. Sytropin HGH Shows Promising Anti-Aging Results
9. Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
10. New smoking cessation therapy proves promising
11. SBRT eliminates tumors with promising survival for early-stage inoperable lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Guruji Mahendra ... 9th, 10th and 11th, 2016 in honor of his birthday on February 10th. ... happiness. Mahendra Trivedi is known by over 250,000 people from over 40 different ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women’s Excellence now ... the most minimally invasive approaches. , Women who have had multiple vaginal births ... factors include surgery to the pelvic floor, connective tissue disorders, and obesity. Women ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd Hobgood , ... medical and surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, ... non-surgical alternative for reduction of fat below the chin (aka the “double chin”). ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX ... warm color grades to their footage. A LUT is a Lookup Table that contains ... the corresponding color indicated by the table. By manipulating each pixel, LUT's can change ...
(Date:2/5/2016)... ... , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami Marathon ... 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox strapped ... Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will strap ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- HemaFlo Therapeutics, Inc. announced today that the United States Patent ... covering the use of NephroFlow to treat acute kidney injury ... said, "We are pleased to secure our rights to such ... PhD, HemaFlo,s founder, said, "We are pleased to secure our ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ...
(Date:2/8/2016)... , Feb. 8, 2016  Dynatronics Corporation ... of advanced-technology medical devices and rehabilitation equipment for ... congratulates the Denver Broncos, football team for winning ... Cullimore Jr. , Chairman and Chief Executive Officer.  ... and we look forward to enhancing their athletic ...
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
Breaking Medicine Technology: